Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
1. Selected dates can't be greater than February 2026. 2. From date can't be greater than To date. 1. Selected dates can't be greater than February 2026. 2. From date can't be greater than To date. 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results